GAO says FDA's foreign drug inspections can be improved

Alarmed by the recent heparin contamination originating from China, the House Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, held a hearing yesterday on how the Food & Drug Administration can ensure drug safety. At the hearing, the Government Accountability Office